← Browse by Condition
Medical Condition

breast neoplasms

Total Trials
20
Recruiting Now
20
Trial Phases
Phase 4, Phase 1, Phase 2
NCT05573893
Recruiting

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

Enrollment
800 pts
Location
Germany
Sponsor
AstraZeneca
View Trial →
NCT07158164 Phase 4
Recruiting

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

Enrollment
100 pts
Location
United States
Sponsor
Rutgers, The State University ...
View Trial →
NCT04608357
Recruiting

Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients

Enrollment
25 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
View Trial →
NCT06938373
Recruiting

Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression

Enrollment
1,000 pts
Location
China
Sponsor
Xiangya Hospital of Central So...
View Trial →
NCT06443645
Recruiting

Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B

Enrollment
50 pts
Location
France
Sponsor
Centre Paul Strauss
View Trial →
NCT07114601 Phase 1
Recruiting

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Enrollment
421 pts
Location
United States, Canad...
Sponsor
Eli Lilly and Company
View Trial →
NCT07396766
Recruiting

Dissemination of BREASTChoice AIM1-B

Enrollment
20 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C...
View Trial →
NCT07297927
Recruiting

Prospective Study on ICG Lymphoscintigraphy Changes Before and After Radiotherapy in Breast Cancer Patients

Enrollment
40 pts
Location
South Korea
Sponsor
Inah Kim
View Trial →
NCT06180642
Recruiting

Reliability and Validity of Ultrasound for the Assessment of Soft Tissue Properties After Breast Cancer Treatment

Enrollment
90 pts
Location
Belgium
Sponsor
Universiteit Antwerpen
View Trial →
NCT02476786 Phase 2
Recruiting

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Enrollment
50 pts
Location
United States
Sponsor
Washington University School o...
View Trial →
NCT07465393
Recruiting

Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors

Enrollment
66 pts
Location
Taiwan
Sponsor
Valeria Chiu
View Trial →
NCT06517212 Phase 2
Recruiting

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

Enrollment
48 pts
Location
United States
Sponsor
Baylor Research Institute
View Trial →
NCT05797545
Recruiting

Comparison of Ultrasound and Breast MRI for Breast Cancer Detection

Enrollment
1,756 pts
Location
South Korea
Sponsor
Samsung Medical Center
View Trial →
NCT06966700 Phase 3
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Enrollment
2,400 pts
Location
United States, Argen...
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06509555
Recruiting

Correlation Between Serum TK1 and Pathological Remission of Breast Cancer With Neoadjuvant Chemotherapy

Enrollment
200 pts
Location
China
Sponsor
Yunnan Cancer Hospital
View Trial →
NCT06464913 Phase 2
Recruiting

Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic Reconstruction

Enrollment
152 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →
NCT04641247 Phase 2
Recruiting

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

Enrollment
30 pts
Location
United States, Austr...
Sponsor
GlaxoSmithKline
View Trial →
NCT06974604 Phase 2
Recruiting

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

Enrollment
60 pts
Location
United States
Sponsor
Brown University
View Trial →
NCT05452213 Phase 4
Recruiting

Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients

Enrollment
1,000 pts
Location
Germany
Sponsor
Institut fuer Frauengesundheit
View Trial →
NCT07472803
Recruiting

Longitudinal Body Composition Assessment in Breast Cancer Patients

Enrollment
100 pts
Location
Taiwan
Sponsor
Taipei Tzu Chi Hospital, Buddh...
View Trial →